Best Stock to Buy: 6 Days to “Judgment Day” for this $2.50 Microcap
Today's Financial News - Posted March 18, 2009
On March 23, 2009, government approval for this Massachusetts microcap’s drug could trigger a volume spike that carries the stock to triple-digit gains.
by J. Christoph Amberger
Baltimore—TFN: By March 23, 2009, behind closed doors, one of the government’s most notorious “Judgment Day Tribunals” will decide the fate of a $2.50 microcap. Our analysts believe that its share price could soar by up to 165%… or plummet by 62% as a result.
Some investors will double their money. Others will lose their shirt.
This company has a truly groundbreaking product the marker. All it takes is the right verdict and this small Massachusetts outfit could be printing its own money.
But there’s a hitch.
The product requires the approval of one of the toughest, hardest-to-please, untouchable juries this side of Purgatory. The wrong verdict could send this stock crashing by 30%… 45%… even 62%.
The members of this committee are considered Special Government Employees. They receive a salary for each meeting day as well as travel and per diem costs. And even though they know that billions of dollars are on the line… that even the anticipation of their verdict can set trading volumes and share prices soaring… they’re stone-cold and objective.
If they vote “yes”, they create millions, if not billions, in new wealth. If they vote “no,” they destroy just as much—if not more.
Just look at the precedents:
* In the 72 hours between Dec. 22 and Dec. 24, 2008, after a favorable decision from the “Tribunal”, $22 million worth of shares in this one company traded hands, soaring by over 440%! Investors who had bought $1,000 worth of shares made as much as $3,660 in gains.
* After Dec. 30, 2008, investors walked away with gains of 300% in three trading days when a micro cap out of Evanston, Illinois received positive news from the Tribunal. Shareholders with a $1,000 investment had the chance to bank gains of over $2,000. An original investment of $10,000 was suddenly worth over $31,900.
* And on Nov. 13, 2008, another $500-million company saw its shares soar thanks to the Tribunal’s decision. Shareholders saw their money more than double in just one day. Shares worth more than $280 million moved that day. Every 100 shares owned kicked out almost $2,000 in cold, hard gains!
But the verdict isn’t always positive. It can be downright horrific.
One vote can make or break even a Blue Chip. Investors who aren’t prepared might as well burn their shares. Because a simple majority vote… one single scientist voting “nay”… can erase fortunes, destroy livelihoods, and send companies into bankruptcy.
Just look what happened on May 8, 2007 when word leaked out from the boardroom that the group voted “no”…
Shares of a $1.5 billion company plummeted by over 68% in a matter of hours—and have been dropping ever since. Nearly a billion dollars in shareholder equity was nearly instantly erased.
In April of last year, it happened again: Someone passed information to Wall Street that the Tribunal was likely to give a thumbs-down to a multi-national, multi-billion dollar company’s latest project.
Investors lost over $8 billion dollars… in a single day. But this board is impervious to the pain it causes. It doesn’t care who it hurts or who it benefits.
In just a few days, by March 23, 2009, this board will gather around the conference table once again.
And we couldn’t be more excited about it!
That day, one tiny micro cap could get the news it’s been waiting for. It has a groundbreaking product in one of the strongest and fastest-growing markets. All it takes is the right verdict and shareholders have a shot at doubling their money overnight.
When the verdict is read, the company’s market cap could easily swell from $195 million to well over $500 million… even two-thirds of a billion dollars. That could mean tremendous gains in as little as 24 hours.
Or the vote could just as easily be a “no-go.”
If that happens, expect to see $95 million—even $115 million!—in shareholder equity wiped clean off the board. That could leave investors trying to explain losses of 47% to 68% on a single position.
But we think there’s a good chance it goes our way. Sure, a preliminary decision was reached back early February. But the real verdict, which typically follows in line with the preliminary decision, is due on the 23rd. Six days from now. There’s still some indecision because the vote was close and two members of the review board didn’t vote. But the odds are about 60/40 in favor, which means there is still room for shares to jump.
In tomorrow’s issue of Hot Stock Confidential, I tell our premium service members just how to pull it off, let me explain what exactly this tiny company and its roughly 175 employees do…
The company is just months away from marketing a treatment that could eliminate or greatly reduce the debilitating arm, leg, foot and facial pain of a rare but devastating hereditary disease.
If approved, its product could greatly improve the lives of nearly 50,000 people… not to mention scores of smart, forward-looking investors. I’d love you to be on our subscriber list when I make my recommendation tomorrow morning. It’s never been easier… or cheaper!… to become one of our premium members!
Next Article: Mergers and Acquisitions: IBM’s bid for Sun (JAVA) good news for Red Hat (RHT) and Satyam (SAY)
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down